Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

Pfizer wastes no time touting Celebrex A day after Whitehouse Station-based Merck abruptly withdrew from the market Vioxx, its blockbuster arthritis drug, Pfizer yesterday moved to promote Celebrex, its competing medicine.
